Creon Amylases 120000 UNT Endopeptidases 76000 UNT Lipase 24000 UNT Delayed Release Oral Capsule Creon
1 INDICATIONS AND USAGE CREON ® is indicated for the treatment of exocrine pancreatic insufficiency in adult and pediatric patients. CREON is indicated for the treatment of exocrine pancreatic insufficiency in adult and pediatric patients.
AbbVie Inc.
CAPSULE ORANGE Creon 1224
Related Pills
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING CREON (
PANCRELIPASE) delayed-release capsules, containing tan-colored enteric-coated
PANCRELIPASE spheres, are supplied as follows: Strength Description Supplied As NDC Number 3,000 USP units of lipase; 9,500 USP units of protease; 15,000 USP units of amylase Two-piece hypromellose capsule, white opaque cap imprinted “CREON 1203”, white opaque body Bottles of 70 0032-0045-70 0032-1203-70 6,000 USP units of lipase; 19,000 USP units of protease; 30,000 USP units of amylase Two-piece hypromellose capsule, orange opaque cap imprinted “CREON 1206”, blue opaque body Bottles of 100 0032-0046-70 Two-piece gelatin capsule, orange opaque cap imprinted “CREON 1206”, blue opaque body Bottles of 100 0032-1206-01 Bottles of 250 0032-1206-07 12,000 USP units of lipase; 38,000 USP units of protease; 60,000 USP units of amylase Two-piece hypromellose capsule, brown opaque cap imprinted “CREON 1212”, colorless transparent body Bottles of 100 0032-0047-70 Two-piece gelatin capsule, brown opaque cap imprinted “CREON 1212”, colorless transparent body Bottles of 100 0032-1212-01 Bottles of 250 0032-1212-07 24,000 USP units of lipase; 76,000 USP units of protease; 120,000 USP units of amylase Two-piece hypromellose capsule, orange opaque cap imprinted “CREON 1224”, colorless transparent body Bottles of 100 0032-2636-01 Bottles of 240 0032-2636-70 Two-piece gelatin capsule, orange opaque cap imprinted “CREON 1224”, colorless transparent body Bottles of 100 0032-1224-01 Bottles of 250 0032-1224-07 36,000 USP units of lipase; 114,000 USP units of protease; 180,000 USP units of amylase Two-piece hypromellose capsule, blue opaque cap imprinted “CREON 1236”, colorless transparent body Bottles of 100 0032-2637-01 Bottles of 240 0032-2637-70 Two-piece gelatin capsule, blue opaque cap imprinted “CREON 1236”, colorless transparent body Bottles of 100 0032-3016-13 Bottles of 250 0032-3016-28 Storage and Handling Store CREON at room temperature, 15°C to 25°C (59°F to 77°F), and protect from moisture. Temperature excursions are permitted between 25°C to 40°C (77°F to 104°F) for up to 30 days. Discard CREON if exposed to higher temperature and moisture conditions higher than 70%. After opening, keep bottle tightly closed between uses to protect from moisture. Keep the desiccant in the bottle if present . Store and dispense CREON in the original container.
More pills like CAPSULE Creon 1224